Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry.
We help our members discover, develop, and deliver innovative medicines and vaccines.
Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines.
Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system.
We aim to achieve these goals by forming effective alliances and supporting policies, improving Canada’s regulatory environment, widen access to innovative medicines and protect intellectual property.
We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.
- BioNova and Innovative Medicines Canada Collaborate on Nova Scotia Life Sciences Research
- Innovative Medicines Canada – Atlantic – Recognizing National Immunization Awareness Week in Atlantic Canada
- Life Sciences offers solutions for growth in Nova Scotia after 2016-17 budget release
- News Release: Innovative Medicines Canada Welcomes Pamela Fralick as New President